HomeARTL • NASDAQ
add
Artelo Biosciences Inc
Previous close
$1.13
Day range
$1.11 - $1.15
Year range
$1.00 - $1.75
Market cap
3.58M USD
Avg Volume
26.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.20M | -54.28% |
Net income | -1.13M | 53.78% |
Net profit margin | — | — |
Earnings per share | -0.35 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.86M | -62.24% |
Total assets | 7.14M | -53.96% |
Total liabilities | 775.00K | -15.85% |
Total equity | 6.36M | — |
Shares outstanding | 3.23M | — |
Price to book | 0.57 | — |
Return on assets | -38.64% | — |
Return on capital | -43.01% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.13M | 53.78% |
Cash from operations | -778.00K | 56.83% |
Cash from investing | 4.25M | 331.99% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 3.48M | 212.86% |
Free cash flow | -553.88K | 56.28% |
About
Founded
May 2, 2011
Headquarters
Website
Employees
5
